Literature DB >> 29607575

Regulation of muscle protein synthesis in an in vitro cell model using ex vivo human serum.

Brian P Carson1,2,3,4, Bijal Patel1,2,3, Miryam Amigo-Benavent1,2,3, Martina Pauk1,2,3, Sunil Kumar Gujulla1,2,3, Sylvia M Murphy1,5, Patrick A Kiely1,4,5, Philip M Jakeman1,2,3.   

Abstract

NEW
FINDINGS: What is the central question of this study? Can medium conditioned by ex vivo human serum regulate muscle protein synthesis in skeletal muscle cells in vitro? What is the main finding and its importance? This study demonstrates that medium conditioned by ex vivo human serum can regulate muscle protein synthesis in skeletal muscle cells in vitro via the mammalian Target of Rapomycin (mTOR) pathway, and this can be regulated differentially by fed and fasted ex vivo human serum. ABSTRACT: Human serum embodies the integrated systemic response to any condition or perturbation, which may regulate muscle protein synthesis (MPS). Conditioning of medium with human serum represents a physiologically relevant method of regulating MPS in vitro. The primary purpose of the study was the development of a model using ex vivo human serum to condition medium and regulate MPS in in vitro skeletal muscle cells. Four young healthy men reported to the laboratory after an overnight fast and were fed with 0.33 g (kg body mass)-1 whey protein. Blood samples were taken before (Fasted) and 60 min postprandial (Fed). Fully differentiated C2C12 skeletal muscle cells were nutrient and serum deprived for 1 h and subsequently treated with medium conditioned with Fasted or Fed ex vivo human serum (20%) for 4 h. The MPS was measured using the surface sensing of translation technique and activation of mTOR, P70S6K and 4EBP1 by Western blot. Fasted and fed ex vivo human serum increased MPS (P < 0.05). Although a strong effect (ƞ2  = 0.36) for increased MPS in Fed relative to Fasted was observed, this was not statistically significant (P > 0.05). Activation of mTOR, P70S6K and 4EBP1 was significantly increased after treatment with Fed compared with Fasted ex vivo human serum (P < 0.05). Here, we developed and optimized the conditions for culture of C2C12 skeletal muscle cells, measurement of MPS and signalling in medium conditioned by ex vivo human serum. Furthermore, the functionality of the model was demonstrated by comparison of the response to medium conditioned by Fasted and Fed ex vivo human serum.
© 2018 The Authors. Experimental Physiology © 2018 The Physiological Society.

Entities:  

Keywords:  muscle protein synthesis; serum; skeletal muscle

Mesh:

Substances:

Year:  2018        PMID: 29607575     DOI: 10.1113/EP086860

Source DB:  PubMed          Journal:  Exp Physiol        ISSN: 0958-0670            Impact factor:   2.969


  4 in total

1.  Incubation of canine dermal fibroblasts with serum from dogs with atopic dermatitis activates extracellular matrix signalling and represses oxidative phosphorylation.

Authors:  Monica Colitti; Bruno Stefanon; Misa Sandri; Danilo Licastro
Journal:  Vet Res Commun       Date:  2022-06-04       Impact factor: 2.459

2.  Enhancing Chimeric Antigen Receptor T Cell Anti-tumor Function through Advanced Media Design.

Authors:  Saba Ghassemi; Francisco J Martinez-Becerra; Alyssa M Master; Sarah A Richman; David Heo; John Leferovich; Yitao Tu; Juan Carlos García-Cañaveras; Asma Ayari; Yinan Lu; Ai Wang; Joshua D Rabinowitz; Michael C Milone; Carl H June; Roddy S O'Connor
Journal:  Mol Ther Methods Clin Dev       Date:  2020-07-09       Impact factor: 5.849

3.  A Fish-Derived Protein Hydrolysate Induces Postprandial Aminoacidaemia and Skeletal Muscle Anabolism in an In Vitro Cell Model Using Ex Vivo Human Serum.

Authors:  Matthew J Lees; David Nolan; Miryam Amigo-Benavent; Conor J Raleigh; Neda Khatib; Pádraigín Harnedy-Rothwell; Richard J FitzGerald; Brendan Egan; Brian P Carson
Journal:  Nutrients       Date:  2021-02-17       Impact factor: 5.717

4.  The Effect of Ex Vivo Human Serum from Liver Disease Patients on Cellular Protein Synthesis and Growth.

Authors:  Sophie L Allen; Alex P Seabright; Jonathan I Quinlan; Amritpal Dhaliwal; Felicity R Williams; Nicholas H F Fine; David J Hodson; Matthew J Armstrong; Ahmed M Elsharkaway; Carolyn A Greig; Yu-Chiang Lai; Janet M Lord; Gareth G Lavery; Leigh Breen
Journal:  Cells       Date:  2022-03-24       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.